Presentation Materials on Financial Results for the Fiscal Year Ended September 2025 | Amvis Holdings,Inc. (7071) timely disclosure

Worth reading

68In focus

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Mixed performance

Direction inferred from the company’s description.

Scale

28.2

EBITDA前年比減少率（%）

Wording

Avoiding a definitive answer

How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFiscal year ended September 202512 items taken from the company’s own explanation

Financial Results Figures (The key points of this material are explained below)

Net Sales¥49,174 million+15.8%

Operating profit¥6,162 million-41.9%

Net income¥3,660 million-50.8%

Operating profit margin12.5 %

Results for the three months of the current quarter

Net Sales

¥12,809 million

EBITDA

¥2,264 million

Operating profit

¥1,465 million

Profit attributable to owners of the parent

¥661 million

Full-year earnings forecast

Fiscal year ending September 2026

Net Sales

¥51,700 million

EBITDA

¥7,100 million

Operating profit

¥3,800 million

Net income for the current fiscal year

¥2,100 million

Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。

2025年9月期修正予想

Net Sales100.2 %

EBITDA100.7 %

What the company explained in this material

Self-assessment against the planThe company's self-assessment against its own plan.

特別調査委員会等の影響を踏まえた修正予想通りの着地

Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.

EBITDA前年差

既存施設売上高増加2,969

Increase in personnel expenses at existing facilities (cost of sales)-3,846

Revenue increase from new facilities3,403

Increase in personnel expenses at new facilities (cost of sales)-2,632

Increase in land rents and rent expenses (cost of sales)-475

Increase in personnel expenses (SG&A)-378

Other-2,556

Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.

2026年9月期医心館事業の新規開設9 Facility

Utilization rateExpected to recover gradually toward the end of the fiscal year

Medical fee revision2026年度の影響を一定考慮

Personnel expenses, etc.Planned to increase, taking into account the impact of inflation and other factors

New initiatives

総合医療支援事業を新たなセグメントとして切り出し
総合医療支援事業で経営コンサル・金融支援・商社機能の3メニューを展開
医心館事業で病院内・隣接地域、不動産流動化、M&A、中古物件、不動産建築受託など多様な開設スキームを活用
社内コミュニケーションツール『TUNAG』を導入
標準ケアマニュアル、標準ケア記録、重症度分類を整備・運用

Key KPIsA metric the company considers important as a management benchmark.

Occupancy rate at existing facilities81.5 %
Occupancy rate at new facilities36.2 %
Percentage of end-of-life care provided in facilities98.9 %
NPS57.1
Average customer satisfaction score8.8 out of 10
看護師配置9.5 対1
看護職員に占める看護師比率99.3 %

Segment results

Ishinkan (medical care housing) business

Net Sales

¥48,641 million

Operating profit

¥5,811 million

Comprehensive Medical Support Business

Net Sales

¥533 million

Operating profit before provisions

¥405 million

Operating profit

¥351 million

Financial targets

Target equity ratio30 %

25年9月末実績43 %

ROIC総合医療支援事業について23年9期3.5%、24年9期21.0%、25年9期28.2%、26年9期27.6%、27年9期27.5%、28年9期30.0%の実績・計画

Market Size / Share

日本のがん死亡者数400,000 people

日本の病床数1,500,000 people

Unit 2beds

医心館が受け入れるがん患者の国内シェア2.1 people

Unit 3%

Number of stores and locations

Number of facilities at period end130 Facility

期中の新規開設28 Facility

期中の増床1 Facility

期中の事業譲受による開設1 Facility

Capacity6,706 Facility

Capacity unitPeople

Number of employees

Recruitment and PlacementDeploy more than 100 nurses and care workers per month who are available for nationwide travel

Capital expenditures

¥10,427 million2025年9月期の投資キャッシュ・フロー

Annual Dividend

Annual dividend per share¥4

Interim Dividend¥0

Year-end dividend¥4

Contents of this document
Item	Details
Document type	Presentation materials for financial results
Fiscal Period Covered	Fiscal year ended September 2025
Net Sales	¥49,174 million (YoY +15.8%)
Operating profit	¥6,162 million (YoY -41.9%)
Net income	¥3,660 million (YoY -50.8%)
Operating profit margin	12.5 %
Results for the three months of the current quarter	Net Sales ¥12,809 million / EBITDA ¥2,264 million / Operating profit ¥1,465 million / Profit attributable to owners of the parent ¥661 million
Full-year earnings forecast	Fiscal year ending September 2026 Net Sales ¥51,700 million / EBITDA ¥7,100 million / Operating profit ¥3,800 million / Net income for the current fiscal year ¥2,100 million
Progress against full-year forecast	2025年9月期修正予想 Net Sales 100.2 % / EBITDA 100.7 %
Self-assessment against the plan	特別調査委員会等の影響を踏まえた修正予想通りの着地
Segment results	Ishinkan (medical care housing) business Net Sales ¥48,641 million / Operating profit ¥5,811 million / Year on year against the same period last year Not disclosed / Comprehensive Medical Support Business Net Sales ¥533 million / Operating profit before provisions ¥405 million / Operating profit ¥351 million / Year on year against the same period last year Not disclosed
Breakdown of Factors Affecting the Change	EBITDA前年差既存施設売上高増加 2,969 / Increase in personnel expenses at existing facilities (cost of sales) -3,846 / Revenue increase from new facilities 3,403 / Increase in personnel expenses at new facilities (cost of sales) -2,632 / Increase in land rents and rent expenses (cost of sales) -475 / Increase in personnel expenses (SG&A) -378 / Other -2,556
Key KPIs	Indicator name Occupancy rate at existing facilities / Value 81.5 % / Year on year against the same period last year Not disclosed, Indicator name Occupancy rate at new facilities / Value 36.2 % / Year on year against the same period last year Not disclosed, Indicator name Percentage of end-of-life care provided in facilities / Value 98.9 % / Year on year against the same period last year Not disclosed, Indicator name NPS / Value 57.1 / Year on year against the same period last year Not disclosed, Indicator name Average customer satisfaction score / Value 8.8 out of 10 / Year on year against the same period last year Not disclosed, Indicator name 看護師配置 / Value 9.5 対1 / Year on year against the same period last year Not disclosed, Indicator name 看護職員に占める看護師比率 / Value 99.3 % / Year on year against the same period last year Not disclosed
Number of stores and locations	Number of facilities at period end 130 Facility / 期中の新規開設 28 Facility / 期中の増床 1 Facility / 期中の事業譲受による開設 1 Facility / Capacity 6,706 Facility / Capacity unit People
Number of employees	Number of Employees Not disclosed / Change during the period Not disclosed / Recruitment and Placement Deploy more than 100 nurses and care workers per month who are available for nationwide travel
Assumptions Underlying the Business Outlook	2026年9月期医心館事業の新規開設 9 Facility / Utilization rate Expected to recover gradually toward the end of the fiscal year / Medical fee revision 2026年度の影響を一定考慮 / Personnel expenses, etc. Planned to increase, taking into account the impact of inflation and other factors
Financial targets	Target equity ratio 30 % / 25年9月末実績 43 % / ROIC 総合医療支援事業について23年9期3.5%、24年9期21.0%、25年9期28.2%、26年9期27.6%、27年9期27.5%、28年9期30.0%の実績・計画
Annual Dividend	Annual dividend per share ¥4 / Interim Dividend ¥0 / Year-end dividend ¥4
Capital expenditures	10,427 百万円（2025年9月期の投資キャッシュ・フロー）
Market Size / Share	日本のがん死亡者数 400,000 people / 日本の病床数 1,500,000 people / Unit 2 beds / 医心館が受け入れるがん患者の国内シェア 2.1 people / Unit 3 %
New initiatives	総合医療支援事業を新たなセグメントとして切り出し, 総合医療支援事業で経営コンサル・金融支援・商社機能の3メニューを展開, 医心館事業で病院内・隣接地域、不動産流動化、M&A、中古物件、不動産建築受託など多様な開設スキームを活用, 社内コミュニケーションツール『TUNAG』を導入, 標準ケアマニュアル、標準ケア記録、重症度分類を整備・運用

Items this document does not state (10)

Ordinary incomeGross Profit MarginSelling, general and administrative expensesUnit price and quantity metricsRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

2025年9月期は、特別調査委員会対応の影響で新規施設の入居調整や既存施設の稼働が低調となり、新規施設の立ち上げが遅れた。また、シフトチェンジによる人員体制の強化で人件費などが増加した。2026年9月期は、稼働率の回復を見込むものの、人件費等の増加と2026年度の診療報酬改定の影響を一定程度織り込んでいる。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.